Real-time enrollment status for this migraine clinical trial
Current Status
Terminated
Checked: April 17, 2026 at 5:01 AM UTC
| NCT Number | NCT04396236 |
| Recruiting Status | Terminated |
| Condition | Migraine |
| Phase | Clinical Trial |
| Target Enrollment | 1,633 participants |
| Active Locations | 77 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | March 10, 2026 (Mar 10, 2026) |
As of April 17, 2026: Clinical trial NCT04396236 is currently terminated participants. This clinical trial study for migraine is not currently accepting new participants at 77 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04396236 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 77 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04396236 was last updated Mar 10, 2026 (March 10, 2026). HelloStudys verifies this status automatically.